Search
Welcome
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
Not a subscriber? Subscribe here
Register Now
  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
                       
Careers & Tenders
Newsletters
Subscribe
The Mail & Guardian
      SUBSCRIBE / Support independent journalism                   CAREERS & TENDERS / Visit careers.mg.co.za                   WHATSAPP? / Follow the M&G WhatsApp channel here            
Login / Register

LOGIN

  • News
    • Africa
    • Business
    • Editorial
    • Education
    • Health
    • Motoring
    • National
    • Sci-tech
    • Sport
    • World
  • Thought Leader
  • Politics
  • Green Guardian
  • Friday
  • Features
    • Buthelezi, the King’s Hand
    • Cabinet Report Cards 2023
    • Cabinet Report Cards 2012-2021
    • The Fiscal Cliff
  • Research World
    • Submissions
    • Papers
  • 200 Young South Africans
  • Events
    • 200 Young South Africans
    • Greening The Future
    • Power Of Women
      • 2024 Edition
    • Critical Thinking Forum
    • Youth Summit
    • Webinars
  • More..
    • Partners
    • Podcasts
    • Crossword
    • Digital Editions
    • Register
    • WhatsApp Channel
    • Login
    • Lost Password

           

blood clots

Low vaccination rates due to access issues and misinformation
Coronavirus
/ 21 August 2021

Low vaccination rates due to access issues and misinformation

Vaccine acceptance has risen to 72%, but inequality remains the biggest stumbling block for poor people’s access to the jab

By Marcia Zali
How rare is very rare? Your questions about blood clots – answered
Coronavirus
/ 9 May 2021

How rare is very rare? Your questions about blood clots – answered

How rare is rare? How are the blood clots from the vaccine trial unusual? How are symptoms tracked?

By Aisha Abdool Karim and Joan Van Dyk
South Africa to continue with J&J vaccine as cabinet lifts suspension
Coronavirus
/ 22 April 2021

South Africa to continue with J&J vaccine as cabinet lifts suspension

Cabinet has lifted the suspension on its Sisonke vaccination programme after calling a halt due to health concerns. But reviewed data has now led to a recommendation that the programme continues

By Eunice Masson
Blood-clot fears delay AstraZeneca vaccine roll-out
Coronavirus
/ 19 March 2021

Blood-clot fears delay AstraZeneca vaccine roll-out

More than a dozen countries have suspended using the company’s Covid-19 vaccine, because of concerns about possible side effects.

By Agence France Presse

MAIL & GUARDIAN

ABOUT

About
Contact
Advertise

SUBSCRIPTIONS

Subscribe
Newsletters

FOLLOW

WhatsApp Channel
Twitter
Facebook
YouTube
Instagram
LinkedIn
TikTok
Threads

FLAGSHIP EVENTS

200 Young South Africans
Power Of Women
Greening The Future

LEGAL & CORRECTIONS

Privacy Policy
Cookie Policy
Ethics & Social Media Policy

RESOURCES

Mail & Guardian Careers
Property for sale


Mail & Guardian

© 2025 The Mail & Guardian. All rights reserved.

  • Login
  • Register
Forgot Password?
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
body::-webkit-scrollbar { width: 7px; } body::-webkit-scrollbar-track { border-radius: 10px; background: #f0f0f0; } body::-webkit-scrollbar-thumb { border-radius: 50px; background: #dfdbdb }